ContextVision AB
OSE:CONTX
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
SE |
ContextVision AB
OSE:CONTX
|
450.3m NOK | 7.8 | ||
US |
Veeva Systems Inc
NYSE:VEEV
|
29.7B USD | 44.4 | ||
US |
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 19.6 | ||
US |
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 16.5 | ||
AU |
Pro Medicus Ltd
ASX:PME
|
13.1B AUD | 129.8 | ||
JP |
M3 Inc
TSE:2413
|
1.1T JPY | 12.9 | ||
US |
Doximity Inc
NYSE:DOCS
|
5.5B USD | 25.9 | ||
US |
Inspire Medical Systems Inc
NYSE:INSP
|
4.8B USD | -131 | ||
SE |
Sectra AB
STO:SECT B
|
47.3B SEK | -73.4 | ||
US |
Goodrx Holdings Inc
NASDAQ:GDRX
|
3.2B USD | 42.7 | ||
US |
Vocera Communications Inc
NYSE:VCRA
|
2.8B USD | 264.4 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.